Associations Between Preconception Weight Loss Drug Use, Gestational Weight Gain, and Development of Gestational Diabetes

Background: Weight loss drugs (WLD) including glucagon-like peptide-1 agonists (GLP-1 agonists) are increasingly used for obesity to promote weight loss and insulin sensitivity. Currently, recommendations are to halt all WLD in pregnancy given undetermined safety profiles or previously identified te...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Kelly Mover, Eden Crowsey, Vanessa Hux, Terrika Jones, Suzanne Lababidi, Bryna Peplinski
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publishing 2025-01-01
Serier:	Women's Health Reports
Fag:	preconception weight loss gestational weight gain weight loss drug
Online adgang:	https://www.liebertpub.com/doi/10.1177/26884844251401523
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!